Kevin J. Bowman
发表
J. Fridman,
H. Koblish,
P. Scherle,
2010,
Molecular Cancer Therapeutics.
M. Bower,
R. Wynn,
Q. Wang,
2017,
ACS medicinal chemistry letters.
R. Wynn,
A. Margulis,
H. Koblish,
2018,
PloS one.
P. O'dwyer,
P. Scherle,
T. Gajewski,
2017,
Clinical Cancer Research.
R. Wynn,
Q. Wang,
J. Fridman,
2010
.
P. O'dwyer,
P. Scherle,
T. Gajewski,
2012
.
P. Scherle,
L. Leffet,
Yanlong Li,
2012,
European journal of pharmacology.
Qian Wang,
Michael Bower,
Richard Wynn,
2009,
Journal of medicinal chemistry.
Kevin J. Bowman,
A. Combs,
W. Frietze,
2016,
Drug Metabolism and Disposition.
Qian Wang,
Beth Thomas,
Richard Wynn,
2010,
Blood.
Jun Yu Li,
Qianqian Wang,
B. Rumberger,
2018,
The Journal of Pharmacology and Experimental Therapeutics.
R. Wynn,
H. Koblish,
Yue Zhang,
2020,
PLoS ONE.
Kevin J. Bowman,
J. Maleski,
Yan Zhang,
2019,
Drug Metabolism and Disposition.
Discovery of Pemigatinib: A Potent and Selective Fibroblast Growth Factor Receptor (FGFR) Inhibitor.
R. Wynn,
H. Koblish,
Yue Zhang,
2021,
Journal of medicinal chemistry.
L. Leopold,
Kevin J. Bowman,
Xuejun Chen,
2017,
Journal of clinical pharmacology.
J. Fridman,
H. Koblish,
P. Scherle,
2010,
Molecular Cancer Therapeutics.
Jun Yu Li,
Qianqian Wang,
B. Rumberger,
2018,
The Journal of Pharmacology and Experimental Therapeutics.